Familial Transthyretin Amyloidosis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Familial Transthyretin Amyloidosis

What is the definition of Familial Transthyretin Amyloidosis?
Familial transthyretin amyloidosis (FTA) is a rare inherited condition characterized by abnormal build-up of a protein called amyloid in the body's organs and tissues. Signs and symptoms depend on where the amyloid protein is building up. Amyloid build-up in the nerves of the peripheral nervous system causes a loss of sensation in the lower limbs, feet, and hands (peripheral neuropathy). Amyloid build-up can also affect the involuntary body functions, such as blood pressure, heart rate, and digestion. Other areas of the body that may be affected are the heart, kidneys, eyes, and gastrointestinal tract. FTA is caused by changes in the TTR gene. Inheritance is autosomal dominant, but not all people with a TTR genetic change will develop FTA. Diagnosis of FTA is suspected by signs and symptoms and confirmed by tissue biopsy and genetic testing.
What are the alternative names for Familial Transthyretin Amyloidosis?
  • Familial transthyretin amyloidosis
  • Amyloidosis Transthyretin related
  • Amyloidosis, hereditary, transthyretin-related
  • Familial amyloid polyneuropathy
  • Hereditary ATTR amyloidosis
  • TTR amyloid neuropathy
  • Transthyretin amyloid neuropathy
  • Transthyretin amyloid polyneuropathy
  • Transthyretin amyloidosis
Who are the top Familial Transthyretin Amyloidosis Local Doctors?
Elite in Familial Transthyretin Amyloidosis
Elite in Familial Transthyretin Amyloidosis
Referral required

Johns Hopkins Bayview Medical Center

Baltimore, MD 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Michael Polydefkis is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Polydefkis is rated as an Elite provider by MediFind in the treatment of Familial Transthyretin Amyloidosis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Transthyretin Amyloidosis, Familial Transthyretin Amyloidosis, Primary Amyloidosis, and Peripheral Neuropathy. Dr. Polydefkis is currently accepting new patients.

Elite in Familial Transthyretin Amyloidosis
Cardiology | Advanced Heart Failure and Transplant Cardiology
Elite in Familial Transthyretin Amyloidosis
Cardiology | Advanced Heart Failure and Transplant Cardiology
Referral may be required

CUIMC/Vivian & Seymour Milstein Family Heart Center

173 Fort Washington Avenue, Floor 4, Suite 617, 
New York, NY 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Mathew Maurer is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist practicing medicine in New York, New York. Dr. Maurer is rated as an Elite provider by MediFind in the treatment of Familial Transthyretin Amyloidosis. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Maurer is board certified in Advanced Heart Failure And Transplant Cardiology, Cardiovascular Disease, and Internal Medicine. Dr. Maurer is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Familial Transthyretin Amyloidosis
Elite in Familial Transthyretin Amyloidosis
Referral may be required
Pozuelo De Alarcon, MD, ES 

Pablo Pavia-Garcia practices practicing medicine in Pozuelo De Alarcon, Spain. Mr. Pavia-Garcia is rated as an Elite expert by MediFind in the treatment of Familial Transthyretin Amyloidosis. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Transthyretin Amyloid Cardiomyopathy, Cardiomyopathy, Transthyretin Amyloidosis, Heart Transplant, and Pacemaker Implantation.

What are the latest Familial Transthyretin Amyloidosis Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis: Prospective Registry and Pilot Study

Summary: The aim of the study is to evaluate coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and proportion of overt microvascular disease, defined as depressed CFR as well as elevated IMR in patients with cardiac amyloidosis. The second objective of this study is to compare results of non-invasive test including serum light chain amount, Doppler echocardiography with 2D strain, an...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center